Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup (Reply) | Haematologica

Fabrice Jardin

首页> 外文期刊>Haematologica >Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup (Reply) | Haematologica

【24h】

Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup (Reply) | Haematologica

机译：通过免疫组织化学对弥漫性大B细胞淋巴瘤的分类显示，老年患者在非GC亚组中较为常见，而在GC亚组中则较年轻（回复）|血液学

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Haematologica》 |2012年第2期|共1页
作者
Fabrice Jardin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup | Haematologica [J] . Ulf Thunberg, Gunilla Enblad, Mattias Berglund Haematologica . 2012,第2期

机译：通过免疫组织化学对弥漫性大B细胞淋巴瘤的分类显示，老年患者在非GC亚组中较为常见，而在GC亚组中则较年轻。血液学
2. Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients. [J] . Thunberg U, Enblad G, Turesson I, Leukemia and lymphoma . 2010,第8期

机译：肿瘤坏死因子的遗传变异以及弥漫性大B细胞淋巴瘤和滤泡性淋巴瘤的风险：瑞典患者亚组之间的差异。
3. Prognostic impact of diffuse large B-cell lymphoma subgroups in patients undergoing autologous SCT. [J] . Hallack-Neto AE, Dulley FL, Coelho-Siqueira SA, Bone marrow transplantation . 2009,第4期

机译：弥漫性大B细胞淋巴瘤亚组对自体SCT患者的预后影响。
4. Survival Prediction in Patients with Diffuse Large B-cell Lymphoma Using Logistic and Neural Network Models [C] . Chin-Chuan Chang, Chien-Hua Chen, Jer-Guang Hsieh, IEEE Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability . 2021

机译：逻辑和神经网络模型弥漫性大B细胞淋巴瘤患者的存活预测
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup (Reply) [O] . Fabrice Jardin 2012

机译：通过免疫组织化学对弥漫性大B细胞淋巴瘤的分类显示老年患者在非GC亚组中较为常见而在GC亚组中则较年轻（回复）
7. Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup (Reply) [O] . Jardin, Fabrice 2012

机译：通过免疫组织化学对弥漫性大B细胞淋巴瘤的分类显示，老年患者在非GC亚组中较为常见，而在GC亚组中则较年轻（回复）

Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup (Reply) | Haematologica

著录项

引文网络

相似文献

相关主题

期刊订阅